Beijing Leadman Biochemistry Co Ltd (300289) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Beijing Leadman Biochemistry Co Ltd (300289) has a cash flow conversion efficiency ratio of 0.007x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥11.89 Million ≈ $1.74 Million USD) by net assets (CN¥1.71 Billion ≈ $250.60 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 300289 company net worth for the company's overall valuation and market capitalisation.
Beijing Leadman Biochemistry Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)
This chart illustrates how Beijing Leadman Biochemistry Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Beijing Leadman Biochemistry Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Beijing Leadman Biochemistry Co Ltd ranked by their cash flow conversion efficiency. Explore how high is Beijing Leadman Biochemistry Co Ltd's earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hearts and Minds Investments Ltd
AU:HM1
|
-0.005x |
|
Soft-World International
TWO:5478
|
0.116x |
|
Chung Hwa Pulp Corp
TW:1905
|
-0.002x |
|
Hangzhou Electn Soul Network
SHG:603258
|
0.008x |
|
DINGDONG CAYMAN 2ADR/3 A
F:945
|
0.279x |
|
Dongguan Chitwing Technology Co Ltd
SHE:002855
|
0.242x |
|
Pareto Bank ASA
OL:PARB
|
-0.015x |
|
Automotive Properties Real Estate Investment Trust
TO:APR-UN
|
0.016x |
Annual Cash Flow Conversion Efficiency for Beijing Leadman Biochemistry Co Ltd (2008–2025)
The table below shows the annual cash flow conversion efficiency of Beijing Leadman Biochemistry Co Ltd from 2008 to 2025. View 300289 live share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥1.67 Billion ≈ $244.48 Million |
CN¥29.16 Million ≈ $4.27 Million |
0.017x | -51.93% |
| 2024-12-31 | CN¥1.72 Billion ≈ $251.48 Million |
CN¥62.41 Million ≈ $9.13 Million |
0.036x | -51.25% |
| 2023-12-31 | CN¥1.80 Billion ≈ $264.07 Million |
CN¥134.42 Million ≈ $19.67 Million |
0.074x | +21.74% |
| 2022-12-31 | CN¥1.78 Billion ≈ $260.54 Million |
CN¥108.93 Million ≈ $15.94 Million |
0.061x | +1.65% |
| 2021-12-31 | CN¥1.98 Billion ≈ $289.46 Million |
CN¥119.06 Million ≈ $17.42 Million |
0.060x | -38.79% |
| 2020-12-31 | CN¥1.38 Billion ≈ $201.75 Million |
CN¥135.56 Million ≈ $19.84 Million |
0.098x | +14.38% |
| 2019-12-31 | CN¥1.45 Billion ≈ $212.18 Million |
CN¥124.65 Million ≈ $18.24 Million |
0.086x | +52.52% |
| 2018-12-31 | CN¥1.44 Billion ≈ $210.34 Million |
CN¥81.02 Million ≈ $11.86 Million |
0.056x | -33.59% |
| 2017-12-31 | CN¥1.43 Billion ≈ $208.55 Million |
CN¥120.97 Million ≈ $17.70 Million |
0.085x | +38.74% |
| 2016-12-31 | CN¥1.34 Billion ≈ $195.60 Million |
CN¥81.78 Million ≈ $11.97 Million |
0.061x | -56.65% |
| 2015-12-31 | CN¥1.26 Billion ≈ $184.37 Million |
CN¥177.82 Million ≈ $26.02 Million |
0.141x | +1267.55% |
| 2014-12-31 | CN¥1.09 Billion ≈ $159.89 Million |
CN¥-13.21 Million ≈ $-1.93 Million |
-0.012x | -111.38% |
| 2013-12-31 | CN¥851.12 Million ≈ $124.55 Million |
CN¥90.45 Million ≈ $13.24 Million |
0.106x | +39.78% |
| 2012-12-31 | CN¥761.02 Million ≈ $111.36 Million |
CN¥57.86 Million ≈ $8.47 Million |
0.076x | -42.81% |
| 2011-12-31 | CN¥220.77 Million ≈ $32.31 Million |
CN¥29.34 Million ≈ $4.29 Million |
0.133x | -60.29% |
| 2010-12-31 | CN¥159.72 Million ≈ $23.37 Million |
CN¥53.46 Million ≈ $7.82 Million |
0.335x | +12.77% |
| 2009-12-31 | CN¥105.32 Million ≈ $15.41 Million |
CN¥31.26 Million ≈ $4.57 Million |
0.297x | +13.30% |
| 2008-12-31 | CN¥83.90 Million ≈ $12.28 Million |
CN¥21.98 Million ≈ $3.22 Million |
0.262x | -- |
About Beijing Leadman Biochemistry Co Ltd
Beijing Leadman Biochemistry Co.,Ltd. researches and develops, manufactures, and sells vitro diagnostic reagents and instruments, and biochemical raw materials in the People's Republic of China. The company offers biochemical raw materials, including enzymes, antigens, coenzymes, antibodies, buffers, enzyme substrates, culture mediums, stain agents, amino acids, and other products for biotechnolo… Read more